
Shandong Fengyuan Chemical Co., Ltd. (SFCC) specializes in the development, manufacturing, and global distribution of a variety of chemical products. The company's core offerings include industrial and refined grades of oxalic acid, alongside numerous oxalate compounds, which it supplies to both Chinese domestic and international clients. Beyond these, SFCC's extensive product portfolio also features critical substances like potassium tetroxalate, lithium iron phosphate, potassium binoxalate, sodium nitrate, and essential lithium cathode materials. These chemical solutions are integral to a diverse range of industries and emerging sectors. They find vital applications in traditional fields such as pharmaceuticals, rare earth processing, fine chemicals, daily consumer products, and textile printing and dyeing. Furthermore, SFCC's products cater to cutting-edge areas including biopharmaceuticals, new energy vehicles, and environmental protection initiatives. Established in Zaozhuang, China, in the year 2000, the company has its headquarters in that location.
Shandong Fengyuan Chemical Co., Ltd. trades as 002805.SZ on SHZ. The company is classified in Basic Materials / Chemicals and reports in CNY.
The current profile places the business in Chemicals. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Detailed operating-segment data is not available for this symbol yet.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
Shandong Fengyuan Chemical Co., Ltd. can be compared against peers such as Guangdong Highsun Meida New Materials Co., Ltd., Shandong Polymer Biochemicals Co., Ltd., Henan Jindan Lactic Acid Technology Co., Ltd, Lucky Film Company,Limited, China Reform Culture Holdings Co., Ltd., Zhejiang Jianye Chemical Co., Ltd..
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of $5.62B, beta of 0.10, and return on equity of N/A.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
002805.SZ currently shows total debt of N/A and beta of 0.10. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.fengyuanhuaxue.com
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.